This reinforces that they are risk factors for PV prognosis, suggesting that their effect on PV prognosis may be achieved through interaction with JAK2 mutational burden and stimulation of leukocyte proliferation, raising the risk of fibrosis or leukemic transformation. This evidence concerns the gene JAK2 and acquired polycythemia vera.